Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Variant acute promyelocytic leukemia translocation (15;17) originating from two subsequent balanced translocations involving the same chromosomes 15 and 17 while preserving the PML/RARA fusion.
Tirado CA, Jahn JA, Scheerle J, Eid M, Meister RJ, Christie RJ, Croft CD, Wallingford S, Heritage DW, Mowrey PN, Meloni-Ehrig AM. Tirado CA, et al. Among authors: meister rj. Cancer Genet Cytogenet. 2005 Aug;161(1):70-3. doi: 10.1016/j.cancergencyto.2005.01.005. Cancer Genet Cytogenet. 2005. PMID: 16080960
A comparison of efficacy of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in the therapeutic setting of chemotherapy-induced myelosuppression.
Beveridge RA, Miller JA, Kales AN, Binder RA, Robert NJ, Harvey JH, Windsor K, Gore I, Cantrell J, Thompson KA, Taylor WR, Barnes HM, Schiff SA, Shields JA, Cambareri RJ, Butler TP, Meister RJ, Feigert JM, Norgard MJ, Moraes MA, Helvie WW, Patton GA, Mundy LJ, Henry D, Sheridan MJ, et al. Beveridge RA, et al. Among authors: meister rj. Cancer Invest. 1998;16(6):366-73. doi: 10.3109/07357909809115775. Cancer Invest. 1998. PMID: 9679526 Clinical Trial.
Randomized trial comparing the tolerability of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in cancer patients receiving myelosuppressive chemotherapy.
Beveridge RA, Miller JA, Kales AN, Binder RA, Robert NJ, Heisrath-Evans J, Koczyk-Scripka K, Pashko S, Norgard MJ, Barnes HM, Taylor WR, Thompson KA, Smith LF, Ueno WM, Dobrzynski RF, Warren RD, Katcher D, Byrne PJ, Dunning DM, Winokur SH, Lockey JL, Cambareri RJ, Butler TP, Meister RJ, Fiegert JM. Beveridge RA, et al. Among authors: meister rj. Support Care Cancer. 1997 Jul;5(4):289-98. doi: 10.1007/pl00009894. Support Care Cancer. 1997. PMID: 9257425 Clinical Trial.
11 results